Blood level determinations of antimicrobial drugs. Some clinical considerations (Q67430649)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:732384%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

title

Blood level determinations of antimicrobial drugs. Some clinical considerations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:732384%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

author name string

W. L. Hewitt

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A732384

24 July 2022

M. C. McHenry

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A732384

24 July 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=732384

24 July 2022

publication date

1 September 1978

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:732384%20AND%20SRC:MED&resulttype=core&format=json

Medical Clinics of North America

13 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:732384%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:732384%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:732384%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

page(s)

1119-1140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:732384%20AND%20SRC:MED&resulttype=core&format=json

Simultaneous antibiotic levels in "breakthrough" gram-negative rod bacteremia

13 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Amphotericin B Pharmacokinetics in Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Chemotherapy of systemic mycoses (second of two parts).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Guidelines for drug therapy in renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

A pharmacologic guide to the clinical use of amphotericin B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

7 January 2021

Ototoxicity of amikacin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Flucytosine and Amphotericin B: Hemodialysis Effects on the Plasma Concentration and Clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Isoniazid Dosage in Patients with Renal Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Gram-negative bacillary endocarditis. Interpretation of the serum bactericial test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Gentamicin pharmacokinetics during hemodialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Gentamicin blood levels: a guide to nephrotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Administration of ticarcillin to patients with severe renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Use of 5-fluorocytosine in patients with impaired renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Drug dosage in patients with renal disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Treatment of disseminated mycotic infectioons. A new approach to amphotericin B therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

"Continuous" vs. "discontinuous" therapy with penicillin; the effect of the interval between injections on therapeutic efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Clinical and pharmacological studies of ticarcillin in gram-negative infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Amphotericin B therapy in an anephric patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Drug Kinetics and Artificial Kidneys1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

The penicillins. A review of strategy and tactics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

7 January 2021

Symposium perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Ticarcillin, a new semisynthetic penicillin active on Pseudomonas aeruginosa: in vitro activity and blood levels in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

The metabolism of 5-fluorocytosine-214C and of cytosine-14C in the rat and the disposition of 5-fluorocytosine-214C in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Drugs, Receptors and Serum Protein Binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Clinical significance of protein binding of the penicillins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Restrictions Imposed on Antibiotic Therapy by Renal Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Ticarcillin vs carbenicillin: Clinical pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Tobramycin and gentamicin concentrations in the serum of normal and anephric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Radioimmunoassay for measurement of gentamicin in blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Impaired renal function and serum levels of rifamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Pharmacokinetics of amikacin in patients with impaired renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Drug therapy: The newer cephalosporins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

7 January 2021

Tobramycin: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Comparative In Vitro Activity and Clinical Pharmacology of Ticarcillin and Carbenicillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Pharmacokinetic study of intravenous rifampicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Animal and human tolerance of high-dose intramuscular therapy with spectinomycin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Antiobiotics in renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Pharmacokinetics of Ticarcillin in Patients with Abnormal Renal Function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

THE ABSORPTION, EXCRETION, AND METABOLIC FATE OF ETHAMBUTOL IN MAN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

The usefulness of in vitro sensitivity tests in antibiotic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Bacterial resistance to antibiotics. A correlation of clinically attainable blood levels with in vitro sensitivity tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Pharmacokinetic interpretation of cephradine levels in serum after intravenous and extravascular administration in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Quality control of serum gentamicin assays--experience of national surveys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Serum Dilution Test for Bactericidal Activity. II. Standardization and Correlation with Antimicrobial Assays and Susceptibility Tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Pharmacology of Gentamicin in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Clinical Pharmacology of Ticarcillin (α-Carboxyl-3-Thienylmethyl Penicillin, BRL-2288)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

A method of determining the effective therapeutic level in the treatment of subacute bacterial endocarditis with penicillin; a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Pharmacokinetic Studies on the Oral Antimycotic Agent 5-Fluorocytosine in Individuals with Normal and Impaired Kidney Function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Studies on the inactivation of isonicotinyl acid hydrazide in normal subjects and tuberculous patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

A Rapid Chemical Assay for Gentamicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

The administration of cephradine to patients in renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Serum versus urinary antimicrobial concentrations in cure of urinary-tract infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

THE LOCALIZATION AND TREATMENT OF URINARY TRACT INFECTIONS: THE ROLE OF BACTERICIDAL URINE LEVELS AS OPPOSED TO SERUM LEVELS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Serum Dilution Test for Bactericidal Activity. I. Selection of a Physiologic Diluent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Amoxycillin: a new semi-synthetic penicillin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

The Kinetics of 5-Fluorocytosine Elimination in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

The proof of efficacy of antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Relation between Dose and Levels of Gentamicin in Blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

Variations between individuals and populations in the acetylation of isoniazid and its significance for the treatment of pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Gram-negative bacteremia: variable clinical course and useful prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931758-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(16)31758-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:732384%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

1 reference